新型ERα靶向PET探针18F-BHPI的制备及初步评价研究

Preparation and Preliminary Evaluation of 18F-BHPI as a Novel PET Probe Targeting Estrogen Receptor Alpha (ERα)

  • 摘要: 雌激素受体α(estrogen receptor alpha,ERα)是乳腺癌诊断及内分泌治疗的重要分子靶点。BHPI是近年来发现的一类新型ERα靶向非甾体小分子化合物,但其放射性标记及分子影像学研究尚未见报道。本研究设计并合成BHPI硼酸酯前体(B-BHPI),采用铜介导亲核氟化反应成功制备PET分子探针18F-BHPI,并对其放射化学性质、体外稳定性、细胞摄取特征及体内生物分布进行初步评价。结果表明,18F-BHPI的放射性转化率(RCC)为(37.75±7.39)%,放化产率(RCY)为(6.28±0.15)%,放化纯度(RCP)为(96.38±1.62)%,比活度为(0.29±0.11) GBq/μmol,LogP为1.10±0.27。该探针在生理盐水和小鼠血清中孵育240 min后仍保持良好的稳定性。细胞实验结果显示,18F-BHPI在ERα阳性MCF-7细胞中的摄取显著高于ERα阴性MDA-MB-231细胞;他莫昔芬、17β-雌二醇及BHPI均可明显抑制其在MCF-7细胞中的摄取,其中BHPI阻断作用最为显著。正常雌性SD大鼠生物分布结果表明,18F-BHPI主要经肝胆系统及肠道代谢,并具有明确的体内分布和清除特征。本研究首次实现了BHPI的放射性标记并成功构建了BHPI分子探针体系,所得18F-BHPI具有良好的理化性质和ERα相关摄取特征,为BHPI体内示踪研究及新型ERα相关PET分子探针的开发提供了实验依据。

     

    Abstract: Estrogen receptor alpha (ERα) is an important molecular target for the diagnosis and endocrine therapy of breast cancer. BHPI is a recently identified class of novel non-steroidal ERα-targeting small molecules; however, no studies on its radiolabeling or molecular imaging applications have been reported to date. In this study, a boronic ester precursor of BHPI (B-BHPI) was designed and synthesized, and the PET molecular probe 18F-BHPI was successfully prepared via a copper-mediated nucleophilic radiofluorination strategy. The radiochemical properties, in vitro stability, cellular uptake characteristics, and in vivo biodistribution of the probe were systematically evaluated. The results showed that 18F-BHPI was obtained with a radiochemical conversion (RCC) of (37.75±7.39)%, a radiochemical yield (RCY) of (6.28±0.15)%, a radiochemical purity (RCP) of (96.38±1.62)%, and a molar activity of (0.29±0.11) GBq/μmol. The LogP value was 1.10±0.27. The probe exhibited excellent stability in both saline and mouse serum, remaining predominantly intact after 240 min of incubation. Cellular uptake studies demonstrated significantly higher accumulation of 18F-BHPI in ERα-positive MCF-7 cells than in ERα-negative MDA-MB-231 cells. Competitive inhibition experiments further revealed that tamoxifen, 17β-estradiol, and BHPI markedly reduced probe uptake in MCF-7 cells, with BHPI showing the strongest blocking effect. Biodistribution studies in normal female SD rats indicated that 18F-BHPI was mainly metabolized through the hepatobiliary and intestinal pathways and displayed a well-defined in vivo distribution and clearance profile. To the best of our knowledge, this study represents the first successful radiolabeling of BHPI and the first construction of a BHPI-based molecular imaging probe. The resulting 18F-BHPI exhibited favorable physicochemical properties and ERα-related uptake characteristics, providing a useful tool for in vivo tracing of BHPI and a promising foundation for the development of novel ERα-related PET molecular probes.

     

/

返回文章
返回